The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease

Abstract

Symptom-driven care is costly even for women with nonobstructive CAD. Our lifetime estimates for costs of cardiovascular care identify a significant subset of women who are unaccounted for within current estimates of the economic burden of coronary heart disease.